Forsyth dentech 2023

Rena D’Souza, DDS, MS, PhD

Director of the National Institute for Dental and Craniofacial Research (NIDCR)

As the director of NIDCR, Dr. Rena N. D’Souza, oversees NIDCR’s annual budget of more than $500.20 million, which supports basic, translational, and clinical research in areas of oral cancer, orofacial pain, tooth decay, periodontal disease, salivary gland dysfunction, craniofacial development and disorders and the oral complications of systemic diseases. A licensed dentist, D’Souza is recognized for her research in craniofacial development, genetics, tooth development, and regenerative dental medicine. Prior to joining NIH, D’Souza was the assistant vice president for academic affairs and education for health sciences at the University of Utah, Salt Lake City. There she also served as a professor of dentistry, the Ole and Marty Jensen chair of the School of Dentistry and professor of neurobiology and anatomy, pathology and surgery in the School of Medicine and the department of biomedical engineering. D’Souza received her bachelor’s degree in dental surgery from the University of Bombay, India, after which she completed her general practice residency. She earned her D.D.S, Ph.D., and master’s degree in pathology/biomedical sciences from the University of Texas Health Science Center in Houston.

Raymond Cohlmia, DDS

Executive Director of the American Dental Association (ADA)

Dr. Raymond Cohlmia directs the largest dental association in the U.S., the American Dental Association, which plays an essential role in advancing the profession and advocating for oral health in America. He graduated from the University of Oklahoma College of Dentistry in 1988. He was in private practice for 26 years before becoming full-time faculty at the OU College of Dentistry, where he served as dean for seven years prior to his ADA appointment. Cohlmia served as District XII Trustee from 2015 to 2019 and was elected to the board of the ADA Science and Research Institute, where he served as its founding chair. His innovative model of clinical care delivery in the college has led many dental institutions to adapt this new model of patient care.

Stephen E. Thorne, IV

Chief Executive Officer and Founder of Pacific Dental Services (PDS)

Stephen Thorne founded Pacific Dental Services® in 1994 when he entered into his first dental practice management contract in Costa Mesa, California. Today, PDS supports nearly 1,000 offices in 24 states. Thorne received his BA from UCLA and his Master’s in Health Administration from Chapman University. He has traveled on multiple PDS® Foundation International Service Trips including Ethiopia and Guatemala where PDS supported clinicians provide dentistry to hundreds of patients abroad.

Daniel Burke, JD

Chief Enterprise Strategy Officer and General Counsel, Pacific Dental Services

Dan Burke joined Pacific Dental Services in 2011. His current responsibilities include leading the enterprise strategy and strategic payor relationships at Pacific Dental Services. Burke also serves as General Counsel, overseeing the legal, legislative affairs, and compliance functions for the company. Burke currently serves on the Centers for Disease Control and Prevention’s National Association of Chronic Disease Directors (CDC-NACDD) Medical-Dental Integration Steering Committee, and is a member of the Boards of Directors of Dentognostics GmbH and Loocid LLC. In partnership with Colgate-Palmolive, he moderates a multi-part webinar series designed to educate clinicians on the importance of understanding the Mouth-Body Connection®. He is a past Chairman of the Board of the Epilepsy Foundation of Orange County and past member of the National Opioid Task Force. Burke received his Bachelor of Arts degree from Amherst College and his law degree from Georgetown University Law Center. He has been recognized as one of the “Top 10 Innovative In-House Lawyers” in the State of California by The Daily Journal, and “General Counsel of the Year” by the Orange County Business Journal. He has also received the Seven Seals Award from the U.S. Department of Defense for his leadership and support of those serving in America’s National Guard and Reserve.

Natalia I. Chalmers, DDS, MHSc, PhD

Chief Dental Officer, CMS

Dr. Chalmers is a board-certified pediatric dentist, oral health policy expert, and public health advocate who brings more than 20 years of clinical, research, industry, and regulatory experience to CMS in her role as Chief Dental Officer in the Office of the Administrator. Previously, Dr. Chalmers served as a Dental Officer at the US Food and Drug Administration. Dr. Chalmers has devoted her career to transforming scientific and health care data and information into actionable insights to address equity, improve care, and better inform policy and funding. Dr. Chalmers completed her Doctor of Dental Surgery degree at the Faculty of Dental Medicine of the Medical University of Sofia, a residency in pediatric dentistry at the University of Maryland School of Dentistry, and a Ph.D. in oral microbiology from the Graduate Partnerships Program of the University of Maryland School of Dentistry and the National Institute for Dental and Craniofacial Research at the National Institutes of Health, Post-doctoral Fellowship at the Forsyth Institute, and Clinical Research Fellowship at the National Institute for Dental and Craniofacial Research, National Institutes of Health. Dr. Chalmers holds a Master’s degree in Clinical Research from Duke Medical University and a Certificate in Drug Development and Regulatory Science from the University of California San Francisco School of Pharmacy. Her research has translated into action, improving oral care and advocating for the role health policy can play across the lifespan—particularly when it embraces dental well-being as a facet of care for the whole person.

Raymond Cohlmia, DDS

Executive Director of the American Dental Association (ADA)

Dr. Raymond Cohlmia directs the largest dental association in the U.S., the American Dental Association, which plays an essential role in advancing the profession and advocating for oral health in America. He graduated from the University of Oklahoma College of Dentistry in 1988. He was in private practice for 26 years before becoming full-time faculty at the OU College of Dentistry, where he served as dean for seven years prior to his ADA appointment. Cohlmia served as District XII Trustee from 2015 to 2019 and was elected to the board of the ADA Science and Research Institute, where he served as its founding chair. His innovative model of clinical care delivery in the college has led many dental institutions to adapt this new model of patient care.

Rena D’Souza, DDS, MS, PhD

Director of the National Institute for Dental and Craniofacial Research (NIDCR)

As the director of NIDCR, Dr. Rena N. D’Souza, oversees NIDCR’s annual budget of more than $500.20 million, which supports basic, translational, and clinical research in areas of oral cancer, orofacial pain, tooth decay, periodontal disease, salivary gland dysfunction, craniofacial development and disorders and the oral complications of systemic diseases. A licensed dentist, D’Souza is recognized for her research in craniofacial development, genetics, tooth development, and regenerative dental medicine. Prior to joining NIH, D’Souza was the assistant vice president for academic affairs and education for health sciences at the University of Utah, Salt Lake City. There she also served as a professor of dentistry, the Ole and Marty Jensen chair of the School of Dentistry and professor of neurobiology and anatomy, pathology and surgery in the School of Medicine and the department of biomedical engineering. D’Souza received her bachelor’s degree in dental surgery from the University of Bombay, India, after which she completed her general practice residency. She earned her D.D.S, Ph.D., and master’s degree in pathology/biomedical sciences from the University of Texas Health Science Center in Houston.

Carline Durocher, JD

Corporate Secretary, General Counsel and VP of Technology Development, Forsyth

Carline is the executive responsible for Forsyth’s legal, compliance and risk functions and board governance. As the Vice President of Technology Development, she is also responsible for spearheading Forsyth’s efforts to develop an oral health innovation ecosystem.

Dai Feng

Co-Founder and Managing Director of CareCapital Advisors Limited

Dai Feng is the co-founder and managing director of CareCapital Advisors Limited, a healthcare focused VC and growth investor managing a multi-billion portfolio of more than 50 healthcare technology and service companies, with a strong focus on dentistry. CareCapital invests hundreds of millions annually in professional, training-driven healthcare businesses. Dentistry is a core focus and includes preventive, restorative, orthodontics, and implant dentistry. The geographic scope is worldwide, encompassing orthodontics in China, Germany, and the US, implant dentistry in Sweden, bone regeneration in South Korea; and imaging technology in France, among others. Software is also a critical part of delivering great products and clinical services. Clinical formats are broad, from multi-specialty hospitals with hundreds of chairs serving urban communities, to digitally enabled clinics extending rural access. CareCapital’s mission is to commercialize innovative technologies and expand healthcare access by strengthening the heritage and community of dentistry. Prior to co-founding CareCapital, Dai Feng was a partner at Warburg Pincus, a private equity firm, and an associate at Goldman Sachs. Dai Feng graduated in engineering sciences from Harvard College in 1997.

Mariya Filipova, MBA

Chief Innovation Officer, CareQuest Innovation Partners

Mariya Filipova is a serial intra-preneur, building and scaling businesses in established healthcare organizations. She currently serves as the chief innovation officer of CareQuest Innovation Partners and the CareQuest Institute for Oral Health, its non-profit parent. In her role, she oversees innovation, incubation, and investment activities aimed at developing solutions that advance oral health access, equity, and integration for all. Prior to Carequest, she was vice president of innovation at Anthem Inc. and served as one of the founding members of the Health Utility Network, now Avaneer Health. Filipova holds a Master of Business Administration degree from Harvard Business School and a Bachelor’s in economics, summa cum laude, from Mount Holyoke College. During the pandemic, Filipova was recognized by Business Insider as one of the 30 Leaders Under 40 Transforming Healthcare today.

Xin Sylvia He, PhD, MS

Managing Partner, Hyfinity Investments

Dr. Xin Sylvia He is the Managing Partner at Hyfinity Investments which is devoted to advance global innovations in partnership with high unmet needs and rich clinical resources in China. Prior, He was the Senior Partner at CDH, one of the leading investment firms in China, where she led investments in leading pharmaceuticals, medical devices and care service companies, with 6 companies going IPO and strategic sales. Before CDH, He was a partner at a boutique firm with exclusive partnership with HSBC Asia Direct Investments for healthcare in China. Earlier, He founded and was CEO of a specialty pharmaceutical company with operations in both US and China. He obtained her PhD in Immunobiology from Yale University, MS in Chemistry from Princeton University and BS from University of Science and Technology of China.

Ron Inge, DDS

Former Chief Dental Officer, VP of Professional Services & COO, Delta Dental MO

Dr. Ron Inge is the former chief dental officer, chief operating officer and vice president of professional services at Delta Dental of Missouri. He joined the organization in 2016. As chief dental officer and vice president of professional services, Inge was responsible for all aspects of the dental networks, serving as the primary liaison with dental professionals, as well as setting and implementing dental policy and procedures. He also coordinated consumer-focused oral health initiatives and assisted in product development. As chief operating officer, he directed the organization’s operations, including the claims and customer service teams. Inge spent the first 15 years of his career in private dental practice. He has served in executive roles at Aetna, Delta Dental of Washington, Delta Dental of California, the American Dental Association, DentiCare of California and AVP Vision Plans. His experience also includes serving as chief dental officer for Western Dental Services, a large dental service organization, in Orange, California. Inge was involved in the original concept and development of the Institute for Oral Health (IOH) in 2006, and served as the organization’s executive director for more than eight years. He served on the boards of the National Association of Dental Plans and the California Association of Dental Plans. Inge is also a member of The Santa Fe Group, which fosters policies and initiates actions to improve oral health, overall health and the well-being of the public. He received his Bachelor of Arts degree in human biology from Stanford University and his Doctor of Dental Surgery degree from the University of California, Los Angeles.

Michael Jones, MBA

President & CEO, Delta Dental AZ

Michael Jones is the president and CEO of Delta Dental of Arizona, the leading dental benefits insurance company in the state whose mission is creating a path to better health and wellness. Jones is also the president of the charitable Delta Dental of Arizona Foundation, which provides much needed funding, education, and dental supplies to those in need across the entire state and is an elected member of Greater Phoenix Leadership Council (GPLC). Jones works closely with the board of directors and Delta Dental’s executive leadership team to create and leverage partnerships that strengthen the organization’s ability to meet current and evolving market demands while remaining true to its mission of creating a path to better health and wellness. Prior to joining Delta Dental of Arizona in 2021, Jones served as managing director and Midwest region healthcare provider lead for Accenture, a global professional services company providing strategy, consulting, digital and technology solutions. Since 2016, Jones specialized in identifying strategic solutions for various health care organizations and led business development activities to grow the consultancy while managing executive-level client relationships. Jones also founded professional consulting firm M. Jones & Associates, LLC in 2005, which he ran as managing partner until 2016, focusing on delivering strategic business and technology solutions to organizations across the country. He brings a wealth of experience from his various c-suite roles at companies like BeTheMatch and CIGNA Behavioral Health. In 2014, Jones was named by Fast Company Magazine as among the “Most Creative People in Business 100” and in 2011, Jones was named by Minneapolis/St. Paul Business Journal “CIO of the Year.” Jones earned his bachelor’s degree in civil engineering from Iowa State University and a master’s in business administration degree from the University of Texas – Austin, where he was a Consortium Fellowship Recipient. Jones is married and has two children.

Sreenivas Koka, DDS, MS, PhD, MBA

Dean, School of Dentistry, University of Mississippi Medical Center

Dr. Sree Koka assumed his current role as dean of the School of Dentistry on April 5, 2021. He is responsible for management of the school’s education, service and research operations, ensuring that all activities of the school align with the institutional mission. Koka received his D.D.S. and his M.S. in prosthodontics from the University of Michigan, his M.B.A. from the MIT Sloan School of Management and his Ph.D. from the University of Nebraska. Koka is former interim chair of Restorative Dentistry at UCLA School of Dentistry and former clinical professor in Advanced Prosthodontics at Loma Linda University School of Dentistry.  He is a Fellow and past president of the Academy of Prosthodontics, a past president of the International College of Prosthodontists, and former chair of MIT’s Sloan School of Management Alumni Board. He has published more than 100 journal articles and book chapters and lectures extensively nationally and internationally. He has been a reviewer for NIH grants and been a principal investigator on grants funded by NIH and industry sources. In addition, Koka is the co-founder of the Future Leaders in Prosthodontics (FLIP) and the Shaping the Future of Implant Dentistry workshop series.

Jeremy Krell, DMD, MBA

Managing Partner, Revere Partners

Jeremy Krell is a general dentist with a combined business background. He is the Managing Partner of Revere Partners, the first independent Venture Capital fund focused on oral health, and RISE Health, the only inclusion-driven Venture Capital fund focused on oral health. Krell previously built out the Barchester Bay Group, a portfolio consisting of over 40 ventures. Krell has held key operator roles at startups including Head of Marketing and Chief Dental Officer at Simplifeye (acquired), based in NYC, and the Chief Marketing Officer of Verena Solutions, based in Chicago. He oversaw provider and clinical growth initiatives at quip (a unicorn business), the oral health and subscription electric toothbrush company and strategic provider innovation and development at Oscar Health (which had an IPO in 2021). Krell is heavily involved in both academia and policy in dentistry. He serves as the Chairman of the Board of Advisors of the Workman School of Dental Medicine at High Point University. Krell also serves as a Member of an ADA SCDI Committee (Working Group or WG 11.9) whose purpose is to advance the Oral Dataset Interoperability Network (ODIN) to align the and comply with regulation (CARES Act) and empower dental professionals, vendors and patients to elevate care to be simplified, open, more convenient and inexpensive. Krell also serves as the Chair of the Business Development Committee for the Massachusetts Dental Society. Krell practiced general dentistry for nearly a decade following his DMD at Tufts, sits on the Boards of many healthcare and dental startups, and is an angel investor and/or advisor in approximately 70 companies. Krell has a 18+ year proven track record with startups through several successful multi-million dollar fundraises and acquisitions. Krell started his career with three web and graphic design startups and moved into a luxury goods and commodity venture, DormAid, for college students. He later founded a venture incubator, CEO in A Box, following his MBA at Chicago Booth. Krell received The CEO of the Year Award and The Next 100 Global – Venture Capital Award from Global Banking & Finance, the VC Innovator of the Year (Healthcare) Award from Pan Finance, the ADSO Innovation Award, The President’s Volunteer Service Lifetime Achievement Award from President Joe Biden, Crain’s Notable in Health Care, Top 100 Healthcare Visionaries award from IFAH USA, Top 100 Doctors from the Global Summits Institute for his commitment to oral health innovation, and 40 under 40 awards from Incisal Edge and YJP. Krell lives with his wife, daughters, and a pug in Westfield, NJ. He enjoys playing and following professional tennis, having attended all US Opens since he was born. Krell is a foodie and has been vegan for over 10 years, before it was cool.

Kentucky Morrow, MS

Principal, Dental Innovation Alliance (DIA)

Kentucky Morrow is a Principal with Dental Innovation Alliance, where he helps lead sourcing, execution, and portfolio support. He was previously a Vice President of Investment Banking at England & Company, a middle-market investment bank focused on the healthcare and technology sectors. While at England & Company, he advised boards of directors and executive teams of leading middle market companies on mergers and acquisitions, raising growth capital, and strategic initiatives. Morrow holds a M.S. degree in Healthcare Management from Johns Hopkins University and a B.A. degree in Economics with a concentration in Finance and Political Science from Emory University.

Andrew Smith

CEO, Association of Dental Support Organizations (ADSO)

Andrew Smith served as executive vice president of government relations and external affairs for Parallel (formerly Surterra Wellness) where he managed the state and federal government relations teams, served as the company’s chief advocate and spokesperson to policymakers and regulators, and led the company’s advocacy and communications goals in the public affairs space. Prior to joining the private sector, Smith spent a decade working in government, campaigns, and public policy. In particular, Smith worked as finance director and senior advisor for Virginia Governor Terry McAuliffe where he oversaw the strategy, development, and implementation of a record-breaking $44 million fundraising operation. Smith is a graduate of Georgetown University with a degree in government and history. Originally from Chicago, Smith now resides in Greenwich, Connecticut.

Stephen E. Thorne, IV

Chief Executive Officer and Founder of Pacific Dental Services (PDS)

Stephen Thorne founded Pacific Dental Services® in 1994 when he entered into his first dental practice management contract in Costa Mesa, California. Today, PDS supports nearly 1,000 offices in 24 states. Thorne received his BA from UCLA and his Master’s in Health Administration from Chapman University. He has traveled on multiple PDS® Foundation International Service Trips including Ethiopia and Guatemala where PDS supported clinicians provide dentistry to hundreds of patients abroad.

Thomas E. Van Dyke, DDS, PhD

VP for Clinical and Translational Research, Forsyth

Dr. Thomas Van Dyke is Vice President for Clinical and Translational Research and Chair of the Department of Applied Oral Sciences. He provides leadership for Forsyth’s clinical research team and is responsible for expanding Forsyth’s clinical presence in the research community. Dr. Van Dyke drives the Institute’s efforts to expand Forsyth’s connections to industry and corporate partners.

Benjamin Wu, DDS, PhD

Chief Scientific Officer, Forsyth

Dr. Benjamin Wu joined Forsyth in January 2023 as the Chief Scientific Officer. Before his appointment at Forsyth, Dr. Wu was the Professor and Chair of the UCLA Division of Regenerative and Reconstructive Sciences for 23 years, and Director of the Weintraub Center for Reconstructive Biotechnology at the UCLA School of Dentistry.

3D Orthobiologic Solutions, LLC

3D Orthobiologic Solutions (3DOS) is developing a customizable, 3D-printed scaffold for repairing and regenerating bone in oral and maxillofacial surgery. Biocompatible materials and structures are optimized to enhance bone regrowth efficiently and maximally. 3DOS' platform will provide an easy-to-use and biodegradable scaffold that will be superior to existing products in speed and quality and offer a high throughput option for oral surgeons and periodontists.

AirPay

Founded by dentists, AirPay specializes in automating the pre-appointment workflow for dental front desk teams around benefits verification, cost calculation, and out of pocket payments.

Amend Surgical

Amend Surgical is redefining adhesive and barrier technologies across oral, dental, and surgical applications. Our platform of bio-inspired technologies will change the standard of care for wet and mechanically demanding environments, including Tissure™ – a resorbable hydrogel and chitosan-based glue and barrier that has the adhesion and mechanical strength to reconnect trigeminal and other peripheral nerves, eliminating the need for suture.

Biolectrics

Biolectrics is commercializing OraFlow, a prescription oral care device that uses microcurrent stimulation to treat periodontitis, the sixth most prevalent health condition in the world. OraFlow overcomes barriers of treatment acceptance by providing a painless, cost-effective take-home treatment for patients who would otherwise avoid care. Biolectrics was selected as one of the top five oral care startups as a member of the SMILE Health 2023 cohort.

Cavisense

Today, cavity detection is done almost exclusively in the office setting. This is critically impacting access to care especially at early stages when cavities are in a reversible stage and can be treated at low costs. Cavisense has developed a cholorimetric based platform capable of identifying cavities from anywhere. Cavisense’s technology is based on propriety materials and methods that change color in a binary fashion when they come in contact with tooth surfaces undergoing active de-mineralization. The company’s market research indicates high interest among dentists and consumers alike to use the device as a screening and monitoring tool both inside and outside of dental offices. Cavisense is now completing its first clinical study funded by Mass Ventures. It is a Harvard/Tufts spin out company currently located at the Harvard innovation labs.

Cutiss

Cutiss is a Swiss clinical stage life-sciences company providing innovation in regenerative medicine, skin tissue engineering, and beyond. We aim to provide patients who suffer from large and deep skin defects with the first personalized and automated skin tissue therapy that is safe, effective, and accessible for children and adults. We are in the process of starting a multicenter European clinical phase III clinical trial for the treatment of acute wound. We have other programs in skin pigmentation and chronic wounds, and we are investigating the need of bioengineered tissue for dental applications.

DeepCare

DeepCare is an AI-native company with 7 years of industry experience. Our goal is to redefine dental care with AI. We've reimagined oral care for over one million patients across 5,000 clinics in 11 countries. We provide AI-copilot treatment design and AI-powered diagnostic and patient engagement solutions.

Dentherapy Ltd.

Based in Aberdeen, Scotland, Dentherapy is focused on developing pioneering, novel oral therapeutic products. The company's team includes dental professionals, formulation experts and key opinion leaders in academia and the oral care industry. Dentherapy has developed Toothboost® Technology, a proprietary formulation with patent filings. Toothboost supports healthy oral microbiome and combines preventative, restorative, and sensory properties, supported by in-vitro studies and consumer trials. Toothboost Oral Mist gives consumers the opportunity to boost their daily oral care routines with it’s easy to use, anytime, anywhere application. Toothboost Mist’s pocket sized ‘no-rinse’ spray application, boosts the saliva’s remineralising and buffering function, enabling consumers to protect their teeth directly after foods, snacks, and drinks, at times when use of toothpaste or mouthwash are not convenient or possible. Dentherapy is committed to developing a system solution of innovative oral therapeutic products using Toothboost® Technology, to refresh and redefine the landscape of whole mouth care.

Flightpath Biosciences, Inc

Flightpath Biosciences, Inc is a private, Series A funded, near-clinical stage life sciences company headquartered in Detroit, Michigan. To date, the company’s primary development focus has been on novel therapies to treat acute Lyme disease, which is advancing and remains ongoing. The company’s lead drug candidate, FP-100, is a narrow-spectrum bactericidal compound with selective activity against spirochetal bacteria and Fusobacterium and limited impact on the gut microbiome.

GreenMark Biomedical Inc

GreenMark Biomedical Inc. is aiming to transform the dental experience by enabling dentists to visualize caries disease better and earlier, and to accurately assess when to treat and make painless, natural repair possible. At the core of GreenMark’s dental technology is its proprietary starch particle technology platform, involving small submicron particles that can be targeted to go exactly where needed, and then bio-resorb after the job is done. By virtue of this platform, GreenMark in essence has a platform that can be applied to multiple applications within healthcare. These small particles are not solid as hard mineral-based nanoparticles, but we refer to them as “nanosponges.” We utilize the function of these particles to load content on the inside and place functional bonds on the outside of these particles. In so doing, GreenMark has developed a general device for the targeted bio-delivery of healthcare solutions.

IR Scientific

IR Scientific (IR-S) is a biomaterials research and development company based in Halifax, Canada. We are focused on the development of cosmetic and therapeutic products and the commercialization of ion release materials for specific roles in consumer, professional, and industrial applications. IR’s first product, Sensi-IP®, delivers unmatched capabilities addressing tooth sensitivity and enamel repair and mineralization, two of the fastest growing categories in oral care. Our ingredient has been independently validated by industry leading test houses and the CPGs that trust them in oral care. In the last year, the company has focused on adding value to Sensi-IP through toothpaste formulation, a refined regulatory strategy, manufacturing and supply chain certainty. We are beginning clinical trials in October, while continuing to consider partnerships outside of oral care to maximize long term return to our shareholders.

Oral Science International, Inc.

Oral Science International Inc. is a privately held entity supported by its affiliate, Oral Science Inc. and strategically headquartered in Montreal, Quebec, Canada. Within our organizations, we have assembled a workforce of approximately 100 highly skilled professionals and expert consultants, all sharing a steadfast commitment to driving innovation in dental care. In response to the urgent need for a rapid, engaging, precise, innovative, and user-friendly oral inflammation test associated with periodontal disease, we proudly introduce PerioMonitorTM. This cutting-edge solution will provide a non-invasive, real time, and visually intuitive means of assessing oral inflammation levels. Our overarching mission is to establish PerioMonitorTM as an indispensable instrument for dental professionals worldwide. This innovative technology will empower practitioners to diagnose periodontal diseases faster, monitor treatment effectiveness, track disease progression, and deliver proactive patient care with greater patient buy in. Furthermore, we are committed to cultivating strategic alliances with dental professionals and stakeholders, fostering relationships that drive the industry forward.

RegendoDent, Inc.

Developing regenerative therapies for the treatment of dental and craniofacial conditions. The company’s first product, RegendoGEL, activates the regenerative properties of a tooth to restore vital pulp and dentin damaged by decay or trauma.

RevBio

RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive. Effective for bone-to-bone as well as bone-to-metal wet field applications, TETRANITE® is a revolutionary biomaterial that promises to transform bone repair—for both patients and clinicians. Inspired by the marine animal the sandcastle worm, TETRANITE is simple chemistry. Bioengineered from the worm’s secreted protein, our synthetic adhesive is the only patented biomaterial which satisfies both the required and desired properties for a bone adhesive: wet field performance, multi-surface bonding, rapid mechanical stability, and controlled biodegradability. The properties of TETRANITE™ include the ability to provide immediate fixation of bone to bone and bone to metal. This adhesive has been shown in multiple animal studies to be a non-toxic and effective way of repairing bone fractures and defects as well as securing implant devices. Existing data has also shown that TETRANITE™ is reabsorbed and replaced with new bone during the natural process of bone remodeling by acting as a scaffold to facilitate bone growth over time.

SmileSonica Inc.

SmileSonica Inc. is an Edmonton, Canada, medical device company focused on evidence-based non-invasive therapeutic ultrasound dental technologies which include 51 owned and licensed patents. The dental industry challenge we are solving is the enhancement of the effectiveness and efficiency of dental treatments involving bone remodeling in orthodontic, periodontal and dental implant treatments. The growing gap between dental patients’ expectations and status-quo solutions is addressed by our portfolio of disruptive patented products: Aevo System™(Orthodontics), Xiry™ Oral Moisturizing Gel (Xerostomia), PerioAid UltraSound System (Periodontics), and Aevo Smart Aligners™(Orthodontics).

Straightwise

StraightWise revolutionizes the orthodontic experience by leveraging 3D printing and digital technology to create the ultimate fully customized braces solution just for you. Our unique treatment system is the first ever to combine the braces and the retainer into one. It’s completely hidden, amazingly smooth, comfortable and crazy effective. You’ll forget you’re wearing braces but you’ll never forget your retainer.

Voyager Dental

Voyager Dental has developed an innovative CAD software platform for the design of dental treatment appliances, from dentures to aligners, to support the transition to next generation digital and cloud-based work flows in dentistry. Our software is unique in deploying automation and AI to significantly reduce design time, while improving quality, standardization, and patient outcomes.